Merck & Co., Inc. (MRK) Shareholders’ equity 2016–2025
Merck & Co., Inc. (MRK) shareholders’ equity at each fiscal year-end, per SEC filings.
$52.6BFY2025 · since FY2016: $40.1B → $52.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $52.6B | +13.6% |
| FY2024 | $46.3B | +23.2% |
| FY2023 | $37.6B | -18.3% |
| FY2022 | $46.0B | +20.4% |
| FY2021 | $38.2B | +50.8% |
| FY2020 | $25.3B | -2.3% |
| FY2019 | $25.9B | -3.0% |
| FY2018 | $26.7B | -22.2% |
| FY2017 | $34.3B | -14.3% |
| FY2016 | $40.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice